Sector: University & Research Institutions

Latest content

The dangers of patent counting to assess technology leadership

Former USPTO Director Andrei Iancu warns that the US is facing “a new Sputnik moment”, but he and others at an online event caution against reading too much into raw numbers

01 September 2022

Why the new CHIPS + Science Act matters for IP

Although many provisions were stripped out of the final version of the legislation, it still contains important tech transfer-related elements, while the huge sums for R&D it envisages are almost certain to spawn more patents

30 August 2022

Top university IP head voices concerns about new UK foreign investment law

Imperial College tech transfer chief Vjera Magdalenic-Moussavi says the recent legislation puts dealmaking in danger

23 August 2022

From academy to industry: China’s new trend and policies on academic technology transfer

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2022

Most universities and research institutes in China are government-funded, and university­-generated intellectual property is considered state-owned property, making concern over the improper disposal, or even loss of, state-owned property the most prominent issue of academic technology transfers.

18 August 2022

Mysterious patent-purchasing biotech now embroiled in trade secrets dispute

New market entrant Terran Biosciences takes action against rival Compass Pathways in Maryland district court

17 August 2022

UK government blocks IP deal with Chinese company using radical new powers

Recently implemented legislation gives the British government the ability to intervene in IP transactions

22 July 2022

There are dangers in excluding the unvaccinated from jury service in US patent cases

Courts striking-out those who have not had covid-19 jabs may unintentionally be eliminating people from diverse demographics holding multiple world views

16 July 2022

Royalty Pharma spends $1.3 billion in latest drug revenue rights purchase

Royalty transactions are an increasingly attractive means of cashing in on life sciences innovation, and the returns can be significant

15 July 2022

Data monetisation gathers momentum in the healthcare sector

Life sciences innovators are increasingly paying for access to high-quality data

27 June 2022

French appeal court SPC decision is good news for biologics innovators

Following a string of adverse rulings against inventors, Paris Court of Appeal overturns patent office rejection of supplementary protection certificate on Article 3(a) grounds

20 June 2022

Unlock unlimited access to all IAM content